Comar has named Brian Larkin as its new President and Chief Executive Officer, succeeding Mike Ruggieri, who will transition to the Chairman role and remain on the Board of Directors. Under Mr. Ruggieri’s 15 years of leadership, Comar evolved from a single site family-owned business to a professionally backed, multi-national company with expanded customer relationships, broad innovation and design resources, and state-of-the-art manufacturing capabilities.
“Brian is the right leader for Comar,” said Mr. Ruggieri, Chairman of the Board. “Brian’s extensive background in the healthcare industry combined with his innate business development skills should help Comar strengthen partnerships, develop strategic alliances, and expand our international sales presence. In addition, we believe his customer-centric leadership style will help focus Comar as we pursue our strategic ambitions.”
Mr. Larkin’s career spans more than three decades of commercial and executive leadership roles in public and private equity-backed companies focused on medical device and pharmaceutical companies. Prior to joining Comar, Mr. Larkin held several key executive positions, including President and Chief Executive Officer of SP Industries, Vice President and General Manager of Becton Dickinson’s U.S. Diabetes Care business, Senior Vice President and General Manager for LifeCell Corporation, and Corporate Vice President of Integra Lifesciences. He also currently serves on the Board of Directors for Dynatronics Corporation.
“I am excited to build upon the strong foundation that Mike and his team have established at Comar and eager to contribute to its next phase of growth,” said Mr. Larkin. “I look forward to partnering with Comar’s employees and valued customers to capitalize on emerging growth trends in the medical and packaging industries while continuing to provide the highest quality products and services.”
Eric Kanter, Managing Director at Morgan Stanley Capital Partners (MSCP), which manages the investment funds backing Comar said, “This is a unique opportunity to bring a fresh perspective to Comar while maintaining seamless continuity. Mike will remain an integral part of the company, while Brian will bring a new vision and a strong customer lens to all aspects of the business. On behalf of MSCP, we would like to thank Mike Ruggieri for his many years of leadership and service to the company, and we look forward to continuing to benefit from his experience and expertise on the Board.”
February 8, 2022Comar Expands Internationally & Acquires Automatic Plastics Ltd.
Voorhees, New Jersey, USA, February 8, 2022 – Comar, a premier supplier of custom medical devices & assemblies and specialty packaging solutions, announced today it has acquired Automatic Plastics Ltd., a contract manufacturer of injection molded products primarily for the medical device and pharmaceutical sectors. The company is headquartered in Wicklow, Ireland just south of
December 28, 2021Comar Expands Packaging Portfolio with Omega Packaging Acquisition
Comar, a premier supplier of custom medical devices and assemblies and specialty packaging solutions, announced today it has acquired Omega Packaging, a manufacturer of injection and blow molded products serving the pharmaceutical, nutraceutical, sports nutrition, and skin care markets. Omega Packaging’s line of child-resistant (CR) closures and precision mold-building capabilities advance Comar’s strategy to serve
December 16, 2021Comar Hosts Ribbon-Cutting Ceremony for West Bend, Wisconsin Plant
West Bend, Wisconsin – Comar, a premier supplier of specialty packaging solutions and custom molded medical devices and assemblies was joined by customers, West Bend’s Mayor Christophe Jenkins, local Chamber of Commerce President and CEO Toni Gumina, several Chamber of Commerce ambassadors, Comar’s engineering partners at Strang, Inc, and their construction partners at Maas Brothers to